Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ottawa Hospital Research Institute
With
Hoffmann-La Roche
Sanofi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary colorectal cancer with unresectable metastatic lesion(s)
At least one measurable lesion, confirmed by CT scan
Male and female patients, aged ≥ 18 years
ECOG performance score of 0 or 1 (within 1 week of study treatment start)
Written informed consent
Adequate general condition, cardiopulmonary functions and performance status
Liver metastases no initially foreseen R0 resection of all hepatic lesions, but deemed potentially resectable after response to downsizing therapy
You may not be if
Extrahepatic metastatic disease
Prior systemic or local treatment for metastatic disease, prior therapy with a biologic agent, prior adjuvant or neo-adjuvant chemotherapy, prior radiotherapy to the liver, other concurrent chemotherapy
Inadequate bone marrow, liver, renal function, uncontrolled hypertension
Pregnancy or lactation
Clareo Health | IXO+A in mCRC With Liver-only Metastases
